Marathon Capital Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.24M Buy
35,836
+686
+2% +$84.8K 0.95% 35
2025
Q4
$4.42M Buy
+35,150
New +$4.58M 0.95% 35
2021
Q4
Sell
-1,865
Closed -$363K 227
2021
Q3
$363K Buy
+1,865
New +$376K 0.08% 134

Other funds holding ZTS

Marathon Capital Management's ZTS Position: Q1 2026 in Review

Marathon Capital Management increased its Zoetis (ZTS) stake by 2% in Q1 2026, buying an estimated $84.8K and bringing the position to 35,836 shares worth $4.24M. The position accounts for 0.95% of the portfolio, ranked #35.

Marathon Capital Management first reported a position in ZTS in Q3 2021 and has held it in 3 quarters since. The position peaked at $4.42M in Q4 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Marathon Capital Management held 35,836 shares of Zoetis worth $4.24M as of Q1 2026.
  • Marathon Capital Management bought 686 Zoetis shares in Q1 2026, an estimated $84.8K.
  • Zoetis made up 0.95% of Marathon Capital Management's portfolio in Q1 2026, its #35 holding.
  • Marathon Capital Management first reported a position in Zoetis in Q3 2021 and has held it in 3 quarters since.
  • Marathon Capital Management's Zoetis position peaked at $4.42M in Q4 2025.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Marathon Capital Management's 13F filing for Q1 2026, filed 14 May 2026.